(Q38067619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

title

The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

main subject

pneumonia

0 references

Streptococcus pneumoniae

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

M H Rozenbaum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

P Pechlivanoglou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

J R Lo-Ten-Foe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M J Postma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

E Hak

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

14 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

305-316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10096-012-1778-4

20 February 2020

exact match

0 references

cites work

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Pneumonia in the very old

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Clinical and economic burden of community-acquired pneumonia among adults in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Controlling the risk of spurious findings from meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Generalized linear mixed models: a practical guide for ecology and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Community-acquired pneumonia in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Aetiological diagnosis of community acquired pneumonia: utility of rapid microbiological methods with respect to disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Aetiology and clinical presentation of mild community-acquired bacterial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Microbial aetiology of community-acquired pneumonia in hospitalised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Pneumonia--a clinical or radiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adults in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Clinical evaluation of the management of community-acquired pneumonia by general practitioners in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Pre- and in-hospital management of community-acquired pneumonia in southern France, 1998-99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Pneumococcal capsular antigen detection and pneumococcal serology in patients with community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Guidelines for severe community-acquired pneumonia in the western world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Simple criteria to assess mortality in patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Prospective study of epidemiology and prognostic factors in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Value of bacterial antigen detection in the diagnostic yield of transthoracic needle aspiration in severe community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Community-acquired pneumonia in the elderly: Spanish multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Microbiological profile of community-acquired pneumonia in adults over the last 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

A hospital study of community acquired pneumonia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Adenosine deaminase activity in the aetiological diagnosis of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Prospective study of community-acquired pneumonia of bacterial etiology in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Efficacy of pneumococcal vaccination in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Viral potentiation of bacterial superinfection of the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Microbiological Testing and Outcome of Patients With Severe Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

A Three-year Study of Severe Community-acquired Pneumonia With Emphasis on Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Severe Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

21 January 2018

Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Current and Potential Usefulness of Pneumococcal Urinary Antigen Detection in Hospitalized Patients With Community-Acquired Pneumonia to Guide Antimicrobial Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-012-1778-4

Community-acquired pneumonia in older patients

21 January 2018

1 reference

12 December 2020

Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study

1 reference

12 December 2020

Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia

1 reference

12 December 2020

European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005.

1 reference

12 December 2020

Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care

1 reference

12 December 2020

The value of routine microbial investigation in community-acquired pneumonia

1 reference

12 December 2020

The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service

1 reference

12 December 2020

Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores

1 reference

12 December 2020

Emerging pathogens of community-acquired pneumonia: a two-year prospective study.

1 reference

12 December 2020

Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization

1 reference

12 December 2020

Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia

1 reference

12 December 2020

Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults

1 reference

12 December 2020

Aetiology and therapy of community-acquired pneumonia: a hospital study in northern Italy. Veneto Pneumonia Research Group

1 reference

12 December 2020

Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia

1 reference

12 December 2020

Urinary detection of Streptococcus pneumoniae antigen for diagnosis of pneumonia

1 reference

12 December 2020

Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia

1 reference

12 December 2020

Community-acquired pneumonia among the elderly: differences between patients living at home and in nursing homes

1 reference

12 December 2020

Penicillin as empirical therapy for patients hospitalised with community acquired pneumonia at a Danish hospital.

1 reference

12 December 2020

Community-acquired pneumonia: is there difference in etiology between hospitalized and out-patients?

1 reference

12 December 2020

Demonstration of circulating pneumococcal immunoglobulin G immune complexes in patients with community-acquired pneumonia by means of an enzyme-linked immunosorbent assay

1 reference

12 December 2020

Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology

1 reference

12 December 2020

Etiologic study of patients with community-acquired pneumonia

1 reference

12 December 2020

Severe community-acquired pneumonia in ICUs: prospective validation of a prognostic score

1 reference

12 December 2020

Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.

1 reference

12 December 2020

Microbial aetiology of community-acquired pneumonia and its relation to severity

1 reference

12 December 2020

Microbial pathogens of adult community-acquired pneumonia in Southern Estonia

1 reference

12 December 2020

Aetiology of, and risk factors for, recurrent community-acquired pneumonia

1 reference

12 December 2020

10.1007/S10096-012-1778-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23242464%20AND%20SRC:MED&resulttype=core&format=json